MedPath

上海信谊金朱药业有限公司

Ownership
-
Established
1993-12-01
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

157

NMPA:157

Drug Approvals

Formoterol Fumarate Inhalation Solution

Product Name
富马酸福莫特罗吸入溶液
Approval Number
国药准字H20254361
Approval Date
May 27, 2025
NMPA

Amisulpride Oral Solution

Product Name
氨磺必利口服溶液
Approval Number
国药准字H20243190
Approval Date
Feb 20, 2024
NMPA

Chloramphenicol Ear Drops

Product Name
氯霉素滴耳液
Approval Number
国药准字H31021984
Approval Date
Mar 14, 2023
NMPA

尼莫地平注射液

Approval Number
国药准字H20057745
Approval Date
Feb 6, 2023
NMPA

Salbutamol Sulfate Inhalation Solution

Product Name
吸入用硫酸沙丁胺醇溶液
Approval Number
国药准字H20227161
Approval Date
Dec 9, 2022
NMPA

Amiodarone Hydrochloride Injection

Product Name
盐酸胺碘酮注射液
Approval Number
国药准字H20223022
Approval Date
Jan 18, 2022
NMPA

Salbutamol Sulfate Injection

Product Name
硫酸沙丁胺醇注射液
Approval Number
国药准字H20217009
Approval Date
Jan 14, 2021
NMPA

鱼肝油酸钠注射液

Approval Number
国药准字H31022749
Approval Date
Nov 23, 2020
NMPA

核酪注射液

Approval Number
国药准字H31022570
Approval Date
Oct 29, 2020
NMPA

氯霉素滴眼液

Approval Number
国药准字H31021985
Approval Date
Oct 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 16
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.